4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000950170-24-011491
Chief Medical Officer sold 28,075 shares at $1.37 ($38,463)
- Chief Medical Officer acquired 239,731 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HAMED KAMAL Chief Medical Officer | 2024-02-01 | Grant or award | +239,731 | 816,192 | D | ||
| HAMED KAMAL Chief Medical Officer | 2024-02-02 | Sale | −28,075 | $1.37 | $38,463 | 788,117 | D |
| Open-market sales · 28,075 sh · avg $1.37 · $38,463 | |||||||
Loading xslF345X05/ownership.xml…